Stock Evaluator: NeOnc Technologies Holdings, Inc. (NTHI)

NeOnc Technologies Holdings, Inc. NTHI

$5.05 0.09 1.81%
September 3, 2026 10:37:34 AM EST November 10, 2021 Volume: 12,764
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Pharmaceuticals

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies. Its lead product candidates include NEO100, a purified form of preillyl acid that is in Phase IIa clinical trial; and NEO212, a covalently conjugated molecule combining chemotherapeutic drug temozolomide with perillyl alcohol that is in Phase I/II clinical trials for its oral administration for the treatment of primary brain cancers, such as meningioma, high grade gliomas, glioblastoma, and secondary brain cancers. The company was formerly known as NAS-ONC, Inc. and changed its name to NeOnc Technologies Holdings, Inc. in 2009. The company was incorporated in 2005 and is headquartered in Calabasas, California.

Commentary & Analysis


Financial Summary

Share Statistics NTHI Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $123.3 $674.0 23%
Shares Out (Mil) 24.7 43.9 34%
Institutional Ownership 10.3% 84.7% 6%
Float (Mil) 8.1 47.3 16%
Beta na 0.71 na
Avg Daily Volume (000s) 147 293 41%
Price Change
(52-week)
(29.9%) 68.8% 24%
Growth NTHI Industry
Median
Percentile
(All Stocks)
Sales (5yr) na 6.8% na
Net Income (5yr) na (1.5%) na
EPS (5yr) na 14.9% na
Dividends (5yr) na 0.0% 0%
Cash Flow (5yr) na (15.1%) na
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 2 2 3
Current EPS ($0.335) ($1.350) ($1.007)
Month Ago EPS ($0.167) ($0.850) ($0.753)
# Rev Up 0 0 0
# Rev Down 0 0 1
Three Months Ago EPS ($0.210) ($0.905) ($0.885)
Year/Year Chg (41.9%) (57.9%) (50.1%)
Financials NTHI Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) na $317 na
Net Income (TTM) (Mil) ($47) ($11) 16%
EPS (TTM) ($2.136) ($0.700) 14%
Operating Cash Flow (TTM) (Mil) ($21) ($7) 14%
Net Cash Flow (TTM) (Mil) na $4 na
Long-Term Debt (Q1) (Mil) $0 $6 13%
Enterprise Value (Q1) (Mil) $139 $575 23%
Valuation NTHI Industry
Median
Percentile
(All Stocks)
P/B na 2.80 na
P/E na 17.4 na
Dividend Yield na 0.0% na
PEG (5yr hist) na 1.1 na
Ratios NTHI Industry
Median
Percentile
(All Stocks)
Gross Margin 100.0% 67.5% 96%
Net Margin na (1.4%) na
ROA na (24.6%) na
ROE 282.0% (21.4%) 99%
Liabilities to Assets 454.2% 32.2% 100%
F-Score 3 3 18%

NeOnc Technologies Holdings, Inc. did not pass any screens on 9/2/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors